标题
Glutamate system as target for development of novel antidepressants
作者
关键词
-
出版物
CNS SPECTRUMS
Volume 18, Issue 04, Pages 188-198
出版商
Cambridge University Press (CUP)
发表日期
2013-02-02
DOI
10.1017/s1092852912000971
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Effects of Propofol and Ketamine as Combined Anesthesia for Electroconvulsive Therapy in Patients With Depressive Disorder
- (2013) Xiaobin Wang et al. JOURNAL OF ECT
- Long-Term Maintenance With Intramuscular Ketamine for Treatment-Resistant Bipolar II Depression
- (2012) Cristina Cusin et al. AMERICAN JOURNAL OF PSYCHIATRY
- Role of BDNF/TrkB signaling in antidepressant-like effects of a group II metabotropic glutamate receptor antagonist in animal models of depression
- (2012) Hiroyuki Koike et al. BEHAVIOURAL BRAIN RESEARCH
- Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial
- (2012) Carlos A. Zarate et al. BIOLOGICAL PSYCHIATRY
- Emerging Targets for the Pharmacological Treatment of Depression: Focus on Melatonergic System
- (2012) Mario Catena-Dell'Osso et al. CURRENT MEDICINAL CHEMISTRY
- Memantine treatment reverses anhedonia, normalizes corticosterone levels and increases BDNF levels in the prefrontal cortex induced by chronic mild stress in rats
- (2012) Gislaine Z. Réus et al. METABOLIC BRAIN DISEASE
- Synaptic Dysfunction in Depression: Potential Therapeutic Targets
- (2012) R. S. Duman et al. SCIENCE
- Therapeutic options in treatment-resistant depression
- (2011) Eduard Vieta et al. ANNALS OF MEDICINE
- Ketamine plus imipramine treatment induces antidepressant-like behavior and increases CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain
- (2011) Gislaine Z. Réus et al. BEHAVIOURAL BRAIN RESEARCH
- Inflammatory and Neurodegenerative Pathways in Depression: A New Avenue for Antidepressant Development?
- (2011) M. Catena-Dell'Osso et al. CURRENT MEDICINAL CHEMISTRY
- Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression
- (2011) Lobna Ibrahim et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression
- (2010) Nancy Diazgranados et al. ARCHIVES OF GENERAL PSYCHIATRY
- Switching Treatments for Complicated Depression
- (2010) Maurizio Fava JOURNAL OF CLINICAL PSYCHIATRY
- A Review of Current Guidelines for Depression Treatment
- (2010) Alan J. Gelenberg JOURNAL OF CLINICAL PSYCHIATRY
- Rapid Resolution of Suicidal Ideation After a Single Infusion of anN-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder
- (2010) Nancy DiazGranados et al. JOURNAL OF CLINICAL PSYCHIATRY
- Rapid Antidepressant Effect of Ketamine Anesthesia During Electroconvulsive Therapy of Treatment-Resistant Depression
- (2010) Nagahisa Okamoto et al. JOURNAL OF ECT
- The Use of a Series of Ketamine Infusions in Two Patients With Treatment-Resistant Depression
- (2010) M. Messer et al. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
- Glutamatergic Modulators: The Future of Treating Mood Disorders?
- (2010) Carlos Zarate et al. HARVARD REVIEW OF PSYCHIATRY
- Targeting glial physiology and glutamate cycling in the treatment of depression
- (2009) Gerald W. Valentine et al. BIOCHEMICAL PHARMACOLOGY
- Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression
- (2009) Marije aan het Rot et al. BIOLOGICAL PSYCHIATRY
- Neurochemical and behavioural effects of acute and chronic memantine administration in rats: Further support for NMDA as a new pharmacological target for the treatment of depression?
- (2009) Gislaine Z. Réus et al. BRAIN RESEARCH BULLETIN
- Neuropeptide and Sigma Receptors as Novel Therapeutic Targets for the Pharmacotherapy of Depression
- (2009) Konstantinos A. Paschos et al. CNS DRUGS
- Second Messenger Modulation: A Novel Target of Future Antidepressants?
- (2009) D. Marazziti et al. CURRENT MEDICINAL CHEMISTRY
- Targeting Glutamatergic Signaling for the Development of Novel Therapeutics for Mood Disorders
- (2009) Rodrigo Machado-Vieira et al. CURRENT PHARMACEUTICAL DESIGN
- Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial
- (2009) Sanjay J. Mathew et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- The Role of the Tripartite Glutamatergic Synapse in the Pathophysiology and Therapeutics of Mood Disorders
- (2009) Rodrigo Machado-Vieira et al. NEUROSCIENTIST
- Ketamine treatment reverses behavioral and physiological alterations induced by chronic mild stress in rats
- (2009) Lêda S.B. Garcia et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- The Role of Oxytocin in Neuropsychiatric Disorders
- (2008) D. Marazziti et al. CURRENT MEDICINAL CHEMISTRY
- An Innovative Design to Establish Proof of Concept of the Antidepressant Effects of the NR2B Subunit Selective N-Methyl-D-Aspartate Antagonist, CP-101,606, in Patients With Treatment-Refractory Major Depressive Disorder
- (2008) Sheldon H. Preskorn et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
- (2008) Gerard Sanacora et al. NATURE REVIEWS DRUG DISCOVERY
- Repeated intravenous ketamine therapy in a patient with treatment-resistant major depression
- (2008) Michael Liebrenz et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus
- (2007) Lêda S.B. Garcia et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started